Vical Advocates DNA Vaccine Approach With Pandemic Influenza Experts
<p>December 11, 2009 (FinancialWire) — Vical Inc. (NASDAQ: VICL) said that the company is addressing an international gathering of pandemic influenza vaccine experts and potential commercial partners to encourage broader use of the company…